Casey Woodring
Stock Analyst at JP Morgan
(0.31)
# 4,029
Out of 4,784 analysts
31
Total ratings
15.79%
Success rate
-20.01%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $155.55 | +6.08% | 7 | Feb 20, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $280 → $265 | $179.07 | +47.99% | 5 | Feb 3, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $61.32 | +53.29% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $39.85 | +39.57% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.43 | +74.93% | 3 | May 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $34.89 | +6.05% | 3 | Feb 14, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $20.83 | +10.42% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $11.77 | +52.93% | 2 | Jan 23, 2023 |
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $155.55
Upside: +6.08%
ICON Public Limited Company
Feb 3, 2025
Maintains: Overweight
Price Target: $280 → $265
Current: $179.07
Upside: +47.99%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $61.32
Upside: +53.29%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $39.85
Upside: +39.57%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.43
Upside: +74.93%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $34.89
Upside: +6.05%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $20.83
Upside: +10.42%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $11.77
Upside: +52.93%